Ig A, Fedor-Chaiken M, Broach JR: Expression of Rous sarcoma virus transforming protein pp 60v-src in Saccharomyces cerevisiae cells. Mol Cell Biol 1987, 7:2180?187. Kornbluth S, Jove R, Hanafusa H: Characterization of avian and viral p60src proteins expressed in yeast. Proc Natl Acad Sci U S A 1987, 84:4455?459. Murphy SM, Bergman M, Morgan DO: Suppression of c-Src activity by Cterminal Src kinase entails the c-Src SH2 and SH3 domains: evaluation with Saccharomyces cerevisiae. Mol Cell Biol 1993, 13:5290?300. Florio M, Wilson LK, Trager JB, Thorner J, Martin GS: Aberrant protein phosphorylation at tyrosine is responsible for the growth-inhibitory action of pp 60v-src expressed in the yeast Saccharomyces cerevisiae. Mol Biol Cell 1994, 5:283?96. Nada S, Okada M, MacAuley A, Cooper JA, Nakagawa H: Cloning of a complementary DNA to get a protein-tyrosine kinase that particularly phosphorylates a adverse regulatory internet site of p60c-src.Formula of cis-Cyclohexane-1,4-diol Nature 1991, 351:69?two. Trible RP, Emert-Sedlak L, Smithgall TE: HIV-1 Nef selectively activates SRC family members kinases HCK, LYN, and c-SRC through direct SH3 domain interaction. J Biol Chem 2006, 281:27029?7038. Nada S, Yagi T, Takeda H, Tokunaga T, Nakagawa H, Ikawa Y, Okada M, Aizawa S: Constitutive activation of Src household kinases in mouse embryos that lack Csk. Cell 1993, 73:1125?135. Superti-Furga G, Fumagalli S, Koegl M, Courtneidge SA, Draetta G: Csk inhibition of c-Src activity needs both the SH2 and SH3 domains of Src. EMBO J 1993, 12:2625?634. Schindler T, Sicheri F, Pico A, Gazit A, Levitzki A, Kuriyan J: Crystal structure of Hck in complex using a Src family-selective tyrosine kinase inhibitor.3-(2-Methoxyethyl)azetidine supplier Mol Cell 1999, three:639?48. Sicheri F, Moarefi I, Kuriyan J: Crystal structure of the Src family tyrosine kinase Hck. Nature 1997, 385:602?09. Engen JR, Wales TE, Hochrein JM, Meyn MA III, Banu OS, Bahar I, Smithgall TE: Structure and dynamic regulation of Src-family kinases. Cell Mol Life Sci 2008, 65:3058?073. Lee C-H, Saksela K, Mirza UA, Chait BT, Kuriyan J: Crystal structure of the conserved core of HIV-1 Nef complexed having a Src household SH3 domain. Cell 1996, 85:931?42. Choi HJ, Smithgall TE: Conserved residues within the HIV-1 Nef hydrophobic pocket are critical for recruitment and activation with the Hck tyrosine kinase. J Mol Biol 2004, 343:1255?268. Wilson MB, Schreiner SJ, Choi HJ, Kamens J, Smithgall TE: Selective pyrrolopyrimidine inhibitors reveal a necessary part for Src loved ones kinases in BcrAbl signal transduction and oncogenesis. Oncogene 2002, 21:8075?088. Meyn MA III, Schreiner SJ, Dumitrescu TP, Nau GJ, Smithgall TE: SRC family kinase activity is essential for murine embryonic stem cell growth and differentiation.PMID:33433739 Mol Pharmacol 2005, 68:1320?330. Meyn MA III, Smithgall TE: Chemical genetics identifies c-Src as an activator of primitive ectoderm formation in murine embryonic stem cells. Sci Signal 2009, 2:ra64. Emert-Sedlak L, Kodama T, Lerner EC, Dai W, Foster C, Day BW, Lazo JS, Smithgall TE: Chemical library screens targeting an HIV-1 accessory factor/host cell kinase complicated recognize novel antiretroviral compounds. ACS Chem Biol 2009, four:939?47. Narute PS, Smithgall TE: Nef alleles from all significant HIV-1 clades activate Src-family kinases and enhance HIV-1 replication in an inhibitor-sensitive manner. PLoS 1 2012, 7:e32561.42. Blagoveshchenskaya AD, Thomas L, Feliciangeli SF, Hung CH, Thomas G: HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway. Cell 2002, 111:853?66.